Atossa Therapeutics Investor Presentation 2022

Atossa Therapeutics is a clinical-stage biopharmaceutical company developing innovative medicines for oncology and infectious diseases, with focus on breast cancer and COVID-19. The company's pipeline includes programs in breast cancer prevention and treatment. This August 2022 presentation outlines the company's development plans and regulatory strategy.